Roszet® (rosuvastatin and ezetimibe) tablets is now available to patients in United States.

Roszet is widely available and affordable.


Please


Please read full Prescribing information at


Rosuvastatin/Ezetimibe tablets are also approved in 28 countries worldwide. Althera makes the product available to patients in these markets through local and regional partnerships.


Click here to see approved European Summary of Product Characteristics


Ezetimibe/Atorvastatin tablets are currently approved in the United States by the US FDA and in several European countries. We anticipate the product to be made available to patients during calendar year 2021.

Click here for more information on the science behind our products.